Market research
27R.F RaySearch Laboratories AB (publ)
F EUR Healthcare
Latest close
As of 27 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 519M
- P/E ratio
- 30.56
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.87
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- SE0000135485
- Market cap
- 519M
- P/E ratio
- 30.56
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.87
About
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Research context
RaySearch Laboratories AB (publ) appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 27R.F discussion.
5 years, 6 months ago
RaySearch Laboratories AB (publ) is currently in a long term uptrend where the price is trading 4.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.
RaySearch Laboratories AB (publ)'s total revenue sank by 49.2% to $119M since the same quarter in the previous year.
Its net income has dropped by 238.3% to $-26M since the same quarter in the previous year.
Finally, its free cash flow fell by 50.1% to $41M since the same quarter in the previous year.
Based on the above factors, RaySearch Laboratories AB (publ) gets an overall score of 2/5.